AnaptysBio Inc buy UBS Group AG
Start price
13.05.26
/
50%
€54.40
Target price
13.05.27
-
Performance (%)
-3.27%
Price
15.05.26
€52.62
Summary
This prediction is currently active. With a performance of -3.27%, the BUY prediction for AnaptysBio Inc by UBS_Group_AG is down slightly. This prediction currently runs until 13.05.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| AnaptysBio Inc | -3.27% |
| iShares Core DAX® | -2,11 % |
| iShares Nasdaq 100 | 1,08 % |
| iShares Nikkei 225® | -2,21 % |
| iShares S&P 500 | 1,60 % |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for ANAB provided by MarketBeat